在社区环境中发生急性过敏反应时,建议激活上腺素和紧急医疗服务:国际共识报告
相关实验视频
Updated: Jan 8, 2026

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.9K
Timothy E Dribin1, Hugh A Sampson2, Aikaterini Anagnostou3
1Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
The Journal of allergy and clinical immunology
|December 12, 2025
概括
专家的共识为过敏反应期间的上腺素和紧急医疗服务 (EMS) 激活提供了明确的指导方针. 这些建议旨在改善患者护理,减少社区环境中不必要的紧急访问.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 紧急医疗 紧急医疗
- 临床实践指南 临床实践指南
背景情况:
- 关于在社区环境中使用上腺素和激活急诊医疗服务 (EMS) 来治疗急性过敏反应的指导意见有限.
- 这种差距导致患者护理不一致,包括不充分使用或过度使用上腺素和可以避免的急诊室访问.
研究的目的:
- 在急性过敏反应期间制定基于共识的推来管理上腺素和激活EMS.
- 解决非最佳患者护理问题,改善社区环境中过敏紧急情况的管理.
主要方法:
- 一个国际专家小组 (34名成员) 从2024年1月到2025年5月开发了临床情景,修饰剂和EMS激活建议.
- 在第一阶段使用了经过修改的Delphi过程来达成共识,随后进行了第二阶段测试,测试了修饰剂对治疗决策的影响.
主要成果:
- 该小组开发了24个场景,9个修改器和12个EMS激活建议.
- 在21个建议使用上腺素,5个修饰剂和10个EMS激活协议的声明上达成共识.
- 第二阶段证实了在2个特定的临床场景中给予上腺素的建议.
结论:
- 在急性过敏反应中成功开发了对上腺素的使用和EMS激活的共识建议.
- 整合到决策支持工具可以增强管理,改善结果,优化医疗保健使用,并赋予患者和护理人员权力.
相关概念视频
Allergic Reactions
31.9K
Overview
31.9K
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Cardiopulmonary Resuscitation IV: Pharmacological Management
580
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
580
Adrenergic Agonists: Mixed-Action Agents
1.3K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.3K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K

